A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors
A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors
Recruiting · NCT07124117 · Registry updated 2026-01-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-01-05 | NCT07124117 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| OBI Pharma, Inc | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China Medical University Hospital | Taichung | Taiwan | 24 |
| NEXT Oncology | San Antonio | United States | 70 |
| Scripps Green Hospital | La Jolla | United States | 14 |
| Shuang Ho Hospital | Taipei | Taiwan | 1 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Wan Fan Hospital | Taipei | Taiwan | 1 |